The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

The US Food and Drug Administration (FDA) has announced it is taking additional steps to ensure more infant formula is being provided to combat the ongoing shortage. The FDA has enabled flexibility when it comes to imports of infant formula into the US. Last week, both Danone's Nutricia business and Bubs Australia agreed to supply products to the country. Bubs Australia has made a commitment to the Biden Administration to provide at least 1.25 million tins, equivalent to around 27.5 billion bottles, through its range of infant formulas. Kristy Carr, founder and CEO of Bubs Australia, commented: "As an Australian infant nutrition specialist, we welcome the opportunity to support American families in this time of need and provide an immediate source of safe, reliable and clean range of infant formula". The FDA also confirmed on Thursday it has expanded its collaboration with Danone's Nutricia business to boost supplies of specialised medical baby formula. Around 500,000 additional cans of specialised medical formula, manufactured by Danone’s Nutricia business, will be imported into the US which will amount to more than five million full-size, eight-ounce bottles. Robert M Califf, food and drugs commissioner at FDA, said in a statement: "We have made tremendous progress, including notable steps in just the past week, which will allow us to immediately begin bringing speciality and infant formula products into the US as quickly as possible". "We continue to work closely with our US government partners and domestic and international manufacturers to identify additional formula product that will be available to parents and caregivers in the weeks and months ahead. It is our goal to ensure that hospitals, speciality pharmacies and retail store shelves will begin seeing adequate supplies again in the coming weeks," he added. The shortage started in February when Abbott Laboratories initiated a recall of formula products following reports of serious bacterial infections in four infants.